These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19578518)
1. Activation of Tissue Remodeling Precedes Obliterative Bronchiolitis in Lung Transplant Recipients. Ramirez AM; Nunley DR; Rojas M; Roman J Biomark Insights; 2008 Jun; 3():351-359. PubMed ID: 19578518 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients. Belperio JA; DiGiovine B; Keane MP; Burdick MD; Ying Xue Y; Ross DJ; Lynch JP; Kunkel SL; Strieter RM Transplantation; 2002 Feb; 73(4):591-9. PubMed ID: 11889437 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. Reynaud-Gaubert M; Marin V; Thirion X; Farnarier C; Thomas P; Badier M; Bongrand P; Giudicelli R; Fuentes P J Heart Lung Transplant; 2002 Jul; 21(7):721-30. PubMed ID: 12100898 [TBL] [Abstract][Full Text] [Related]
4. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. D'Ovidio F; Mura M; Tsang M; Waddell TK; Hutcheon MA; Singer LG; Hadjiliadis D; Chaparro C; Gutierrez C; Pierre A; Darling G; Liu M; Keshavjee S J Thorac Cardiovasc Surg; 2005 May; 129(5):1144-52. PubMed ID: 15867792 [TBL] [Abstract][Full Text] [Related]
5. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Scholma J; Slebos DJ; Boezen HM; van den Berg JW; van der Bij W; de Boer WJ; Koëter GH; Timens W; Kauffman HF; Postma DS Am J Respir Crit Care Med; 2000 Dec; 162(6):2221-5. PubMed ID: 11112142 [TBL] [Abstract][Full Text] [Related]
6. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Reynaud-Gaubert M; Thomas P; Badier M; Cau P; Giudicelli R; Fuentes P Am J Respir Crit Care Med; 2000 Jun; 161(6):1924-9. PubMed ID: 10852768 [TBL] [Abstract][Full Text] [Related]
15. Metalloproteinase Profiling in Lung Transplant Recipients With Good Outcome and Bronchiolitis Obliterans Syndrome. Heijink IH; Rozeveld D; van der Heide S; van der Bij W; Bischoff R; van Oosterhout AJ; van der Toorn M Transplantation; 2015 Sep; 99(9):1946-52. PubMed ID: 25651312 [TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation. Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156 [TBL] [Abstract][Full Text] [Related]
17. Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Borthwick LA; Parker SM; Brougham KA; Johnson GE; Gorowiec MR; Ward C; Lordan JL; Corris PA; Kirby JA; Fisher AJ Thorax; 2009 Sep; 64(9):770-7. PubMed ID: 19213777 [TBL] [Abstract][Full Text] [Related]
18. Iron overload and nitric oxide-derived oxidative stress following lung transplantation. Reid D; Snell G; Ward C; Krishnaswamy R; Ward R; Zheng L; Williams T; Walters H J Heart Lung Transplant; 2001 Aug; 20(8):840-9. PubMed ID: 11502406 [TBL] [Abstract][Full Text] [Related]
19. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients. Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030 [TBL] [Abstract][Full Text] [Related]